Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Daniel Tamez"'
Autor:
Anne-Marie Ginn-Hedman, Brad R. Weeks, Katherine Chorpenning, Courtney N. Kaulfus, Staci L. Jessen, Daniel Tamez
Publikováno v:
The Journal of Heart and Lung Transplantation. 40:56-64
Background Histology of thrombosis events in left ventricular assist devices (LVADs) may point to differences between the etiology of either ingested or de novo thrombus formation within LVADs. Materials ingested by the pump would have features sugge
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::557cf17d4578eef72fc158b10b8ddaa5
https://doi.org/10.1016/j.healun.2020.10.007
https://doi.org/10.1016/j.healun.2020.10.007
Autor:
Daniel Tamez, Stephane Mahr, Marcus Granegger, Thomas Haberl, Philipp Aigner, Francesco Moscato, Heinrich Schima, Joel D. Graham, Nathalie J. Nunez
Publikováno v:
Artificial Organs. 40:1113-1120
New left ventricular assist devices (LVADs) offer both important advantages and potential hazards. VAD development requires better and expeditious ways to identify these advantages and hazards. We validated in an isolated working heart the hemodynami
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d4cb82d5ec1d1f002d240ce917425d22
https://doi.org/10.1111/aor.12730
https://doi.org/10.1111/aor.12730
Autor:
Neil Voskoboynikov, Jeffrey A. LaRose, Michael C. Brown, Nathalie J. Nunez, Carlos Reyes, Daniel Tamez, Katherine Chorpenning, Daniel Burkhoff
Publikováno v:
ASAIO Journal. 62:15-19
Controller algorithms are an important feature for assessment of ventricular assist device performance. Flow estimation is one algorithm implemented in the HeartWare continuous-flow ventricular assist device pump system. This parameter estimates flow
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8786046c949d06488147052a5716358d
https://doi.org/10.1097/mat.0000000000000295
https://doi.org/10.1097/mat.0000000000000295
Autor:
Daniel Tamez, Michael Ashenuga, Katherine Chorpenning, Charles R. Shambaugh, M. Ertan Taskin, Anne E. Dierlam, Jeffrey A. LaRose, Carlos Reyes, Anson Cheung
Publikováno v:
Innovations (Philadelphia, Pa.)
Objective Ventricular assist device (VAD) miniaturization is one design trend that may result in less-invasive implantation techniques and more versatility with patient selection. The MVAD System is a miniature, continuous-flow device implanted in th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17fa02e40ee24a74aa4a26616e3d9f9f
https://doi.org/10.1097/imi.0000000000000155
https://doi.org/10.1097/imi.0000000000000155
Autor:
Guruprasad A. Giridharan, Leslie C. Sherwood, Gretel Monreal, Kevin G. Soucy, Steven C. Koenig, Mark S. Slaughter, Charles R. Shambaugh, Katherine Chorpenning, Daniel Tamez, Jeffrey A. LaRose, Michael A. Sobieski
Publikováno v:
ASAIO Journal. 60:170-177
Implantation of ventricular assist devices (VADs) for the treatment of end-stage heart failure (HF) falls decidedly short of clinical demand, which exceeds 100,000 HF patients per year. Ventricular assist device implantation often requires major surg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7dd3f656fc412a3956a8eb8735f4b935
https://doi.org/10.1097/mat.0000000000000038
https://doi.org/10.1097/mat.0000000000000038
Publikováno v:
ASAIO Journal. 51:224-229
In an ovine feasibility study, we implanted two HeartMate-III centrifugal ventricular assist devices (VADs) for total heart replacement. With cardiopulmonary bypass support, both ventricles were transected at the atrioventricular groove, preserving a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79ee8e4f01ed4452c1a75b5ae5f4f9e6
https://doi.org/10.1097/01.mat.0000160400.84250.87
https://doi.org/10.1097/01.mat.0000160400.84250.87
Autor:
Kenneth A. Golden, Daniel Tamez, Jeff L. Conger, Branislav Radovancevic, Kamuran A. Kadipasaoglu, Katherine Robert, S. R. Moore, Igor D. Gregoric, O.H. Frazier, Michel Kindo
Publikováno v:
ASAIO Journal. 50:444-450
The Jarvik 2000 ventricular assist device (VAD) is clinically efficacious for treating end-stage left ventricular failure. Because simultaneous right ventricular support is also occasionally necessary, we developed a biventricular Jarvik 2000 techniq
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9861493c44c8f8312d9ca7fc1f63e9d8
https://doi.org/10.1097/01.mat.0000139304.34821.f1
https://doi.org/10.1097/01.mat.0000139304.34821.f1
Autor:
Branislav Radovancevic, Hyun Keun Chee, Bojan Vrtovec, Robert Jarvik, Egemen Tuzun, Daniel Tamez, S. R. Moore, O.H. Frazier, Igor D. Gregoric
Publikováno v:
ASAIO Journal. 49:604-607
Patients with congestive heart failure who are supported with a left ventricular assist device (LVAD) may experience right ventricular dysfunction or failure that requires support with a right ventricular assist device (RVAD). To determine the feasib
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3aa44ee8c09324ec913aa7cfec92408
https://doi.org/10.1097/01.mat.0000084109.47034.8a
https://doi.org/10.1097/01.mat.0000084109.47034.8a
Biventricular Continuous Flow VADs Demonstrate Diurnal Flow Variation and Lead to End-Organ Recovery
Autor:
Daniel Tamez, Michael C. Brown, Umraan S. Ahmad, Patrick M. McCarthy, Sukit Chris Malaisrie, Edwin C. McGee, Richard T. Lee, Neil Voskoboynikov
Publikováno v:
The Annals of Thoracic Surgery. 92:e1-e3
HeartWare continuous flow ventricular assist devices (HVAD) configured as biventricular assist devices maintain diurnal flow variation, lead to end-organ recovery, and provide for a successful bridge-to-heart transplantation in the first successful N
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bbccfc7baa5f451b17540af99651c399
https://doi.org/10.1016/j.athoracsur.2011.02.081
https://doi.org/10.1016/j.athoracsur.2011.02.081
Publikováno v:
ASAIO journal (American Society for Artificial Internal Organs : 1992). 60(5)
As a result of stagnant heart transplantation rates, ventricular assist devices (VADs) have become a widely accepted therapy for the treatment of advanced-stage heart failure. Long-term reliability of VADs will become increasingly vital as the popula
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::614414fa4bf58a3a2863d354ea333898
https://pubmed.ncbi.nlm.nih.gov/24814839
https://pubmed.ncbi.nlm.nih.gov/24814839